MAGE-A4-directed TCR-T in the Treatment Amongst Subjects With Advanced Solid Tumors

NCT06170294 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: TCR-MAGE-A4 T-Cells

Sponsor

Peking University

Collaborators

[object Object]